Page last updated: 2024-08-22

tranylcypromine and Teratocarcinoma

tranylcypromine has been researched along with Teratocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhowmik, P; Hoang, N; Leng, F; Lu, F; Saxena, L; Vo, V; Yin, F; Zhang, C; Zhang, H; Zhang, X; Zheng, G	1

Other Studies

1 other study(ies) available for tranylcypromine and Teratocarcinoma

Article	Year
New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells. Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8 Topics: Animals; Antineoplastic Agents; Carcinoma, Embryonal; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; Histone Demethylases; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship; Teratocarcinoma	2018

Article

Year

New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.

Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8

Topics: Animals; Antineoplastic Agents; Carcinoma, Embryonal; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; Histone Demethylases; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship; Teratocarcinoma

2018